Viveve Medical (NASDAQ:VIVE) reported quarterly losses of $(0.67) per share which met the analyst consensus estimate. This is a 16.25 percent increase over losses of $(0.80) per share from the same period last year. The company reported quarterly sales of $1.60 million which missed the analyst consensus estimate of $1.73 million by 7.51 percent. This is a 10.34 percent increase over sales of $1.45 million the same period last year.
3 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
